CAMBRIDGE, Mass.--(BUSINESS WIRE)--Altus Pharmaceuticals Inc. (NASDAQ: ALTU), a biopharmaceutical company focused on oral and injectable protein therapeutics for patients with gastrointestinal and metabolic disorders, is scheduled to participate in the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference at the Grand Hyatt Hotel in New York on Tuesday, February 6, 2007.
